US stocks moved lower on Monday as March kicked off, navigating heightened geopolitical risk following…
Read More »
Shares of the AI chip leader fell more than 4% after reporting fiscal fourth-quarter results that beat Wall Street expectations…
Read More »
U.S. stocks traded higher on Wednesday as investors awaited Nvidia’s highly anticipated earnings report, widely viewed as a crucial test…
Read More »
U.S. software stocks surged on Tuesday after fresh announcements from AI startup Anthropic soothed fears that AI is rapidly upending…
Read More »
Zymeworks soared 34% after its partnered drug Ziihera posted strong Phase 3 data, with Jazz Pharmaceuticals showing it improved outcomes…
Read More »
Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist…
Read More »
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast…
Read More »
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster…
Read More »
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after…
Read More »
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by…
Read More »
Cannabis stocks rallied this Friday after reports that the Trump administration is considering easing federal…
Read More »
